Capital and Financing Transactions (Tables)

9 Months Ended

Sep. 30, 2015

Schedule of revolving credit facilities and term loans

At September 30, 2015 and December 31, 2014, the Company had $550.0 million and $481.5 million outstanding, respectively, under the following credit facilities (in thousands):



Credit Facilities	Interest Rate	Initial Maturity	Outstanding Balance at September 30, 2015		Outstanding Balance at December 31, 2014
$10.0 Million Working Capital Revolving Credit Facility	1.7%	03/30/2018	$	—	$	—
$450.0 Million Revolving Credit Facility	1.5%	03/30/2018	—		131,500
$250.0 Million Five-Year Term Loan	2.6%	03/29/2019	250,000		250,000
$200.0 Million Five-Year Term Loan	1.5%	06/26/2020	200,000		—
$100.0 Million Seven-Year Term Loan	4.4%	03/31/2021	100,000		100,000
			$	550,000	$	481,500

Schedule of the effect of derivative financial instruments on consolidated statements of operations and comprehensive income (loss)

The table below presents the effect of the Company's derivative financial instruments on the Company's consolidated statements of operations and comprehensive income (loss) for the three and nine months ended September 30, 2015 and 2014 (in thousands):



Derivatives in Cash Flow Hedging Relationships (Interest Rate Swaps)	Three Months Ended September 30,					Nine Months Ended September 30,
	2015			2014		2015			2014
Amount of gain (loss) recognized in other comprehensive income on derivatives	$	(5,457	)	$	1,448	$	(9,882	)	$	(6,426	)
Net loss reclassified from accumulated other comprehensive loss into earnings	$	1,883		$	1,915	$	5,475		$	5,441
Amount of loss recognized in income on derivatives (ineffective portion, reclassifications of missed forecasted transactions and amounts excluded from effectiveness testing)	$	623		$	41	$	1,868		$	238